1. Corporate Officers - S
2. Saccomano Nicholas A

Insider Trading History of Saccomano Nicholas A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Saccomano Nicholas A since 2015. This trader's CIK number is 1609284. At the time of last reporting, Saccomano Nicholas A was the President and CEO of Onkure Therapeutics, Inc.. (stock ticker symbol OKUR). Also see all insider trading activities at Onkure Therapeutics, Inc..

Note that in the past Saccomano Nicholas A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Onkure Therapeutics, Inc. (OKUR) by Saccomano Nicholas A

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	OKUR	0	$0	962	$2,778	0	$0

Yearly summary of insider trading at Array Biopharma Inc (ARRY) by Saccomano Nicholas A

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	ARRY	0	$0	187,264	$4,041,718	296,250	$1,074,141
2018	ARRY	0	$0	0	$0	30,797	$0
2017	ARRY	0	$0	0	$0	12,343	$0
2015	ARRY	0	$0	0	$0	11,453	$91,165

Insider trading activities at 2 companies by Saccomano Nicholas A:

1. Onkure Therapeutics, Inc. (OKUR)

2. Array Biopharma Inc (ARRY)

Table 1. Insider trading of Onkure Therapeutics, Inc. (OKUR) by Saccomano Nicholas A

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-06-23	OKUR	Sale	88	2.38	209
2025-04-07	OKUR	Sale	516	2.67	1,378
2025-04-04	OKUR	Sale	358	3.33	1,191

Table 2. Insider trading of Array Biopharma Inc (ARRY) by Saccomano Nicholas A

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-04-01	ARRY	Option Ex	13,750	.00	0
2019-02-07	ARRY	Option Ex	187,264	3.60	674,150
2019-02-07	ARRY	Sale	187,264	21.58	4,041,718
2019-01-31	ARRY	Option Ex	95,236	4.20	399,991
2018-12-16	ARRY	Option Ex	12,469	.00	0
2018-06-27	ARRY	Option Ex	11,453	.00	0
2018-04-01	ARRY	Option Ex	6,875	.00	0
2017-12-16	ARRY	Option Ex	5,468	.00	0
2017-04-01	ARRY	Option Ex	6,875	.00	0
2015-03-01	ARRY	Option Ex	11,453	7.96	91,165

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Saccomano Nicholas A (President and CEO of Onkure Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month